Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction

Axxima Pharmaceuticals AG

Division of Agennix Inc./GPC Biotech AG
www.axxima.com

Latest From Axxima Pharmaceuticals AG

Bookmark

German Biotech: Coalescing around the Haves

Positive signs are coming out of German biotech for the first time in years. Scientific output remains strong. The subsector boasts its first profitable pharmaceutical-oriented company; several on- or near-market products, and even a nascent IPO market. The fact that dozens of companies are expected to go bust this year is another sign of the industry's maturation. The long-awaited consolidation predicted in the wake of the Neuer Markt demise is seemingly finally happening. The have-nots are finally beginning to cluster around the haves.
BioPharmaceutical Strategy
Bookmark
  • News

U3 Pharma AG

By Melanie Senior
German start-up U3 Pharma AG is hoping that its focus on, and understanding of, full biological systems rather than simply on chemistry will give it a chance to win the race to find new cancer drugs.
BioPharmaceutical Europe
Bookmark
  • Analysis

European Biotechnology--A Question of Control

By Melanie Senior
European biotech companies have only partnered a third of the development drugs in their collective pipelines. With product-hungry Big Pharma prepared to pay ever-higher prices to in-license, much of the European biotech industry is in a strong position.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • VirGene Pharmaceuticals AG
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Agennix Inc.
  • Senior Management
  • Ranier Wessel, Pres. & CEO
    Christian Wallasch, PhD, VP, Pre-Clinical Dev.
    Clive Krückemeyer , VP, Fin.
    Matthias Stein-Gerlach, PhD, VP, Bus. Dev.
  • Contact Info
  • Axxima Pharmaceuticals AG
    Phone: (49) 89 740 1650
    Am Klopferspitz 19
    Martinsried, 82152
    Germany
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By